1. Home
  2. TNGX vs RFI Comparison

TNGX vs RFI Comparison

Compare TNGX & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$9.32

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Total Return Realty Fund Inc.

RFI

Cohen & Steers Total Return Realty Fund Inc.

HOLD

Current Price

$10.92

Market Cap

294.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNGX
RFI
Founded
2014
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
294.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TNGX
RFI
Price
$9.32
$10.92
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$12.50
N/A
AVG Volume (30 Days)
2.6M
69.8K
Earning Date
11-04-2025
01-01-0001
Dividend Yield
N/A
8.25%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,501,000.00
N/A
Revenue This Year
$53.01
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
53.29
N/A
52 Week Low
$1.03
$9.62
52 Week High
$11.20
$12.52

Technical Indicators

Market Signals
Indicator
TNGX
RFI
Relative Strength Index (RSI) 52.39 29.91
Support Level $8.89 $11.06
Resistance Level $10.22 $11.46
Average True Range (ATR) 0.63 0.11
MACD -0.14 -0.02
Stochastic Oscillator 20.91 5.42

Price Performance

Historical Comparison
TNGX
RFI

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About RFI Cohen & Steers Total Return Realty Fund Inc.

Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.

Share on Social Networks: